1-12 of 12
Andrew Kent
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment-Related and De Novo Ccus Have Similar Molecular Features and Risk of Progression to Myeloid Malignancies

Jennifer Santos, Diana Abbott, Grace Bosma, Andrew Kent, Marc Schwartz, Christine M. McMahon, Jonathan Gutman, Daniel A Pollyea, Maria L Amaya
Journal: Blood
Blood (2024) 144 (Supplement 1): 5649.
https://doi.org/10.1182/blood-2024-201062
Published: 2024
Journal Articles

Omacetaxine and Azacitidine for Newly Diagnosed Patients with Myelodysplastic Syndromes and Excess Blasts

Daniel A Pollyea, Brett M Stevens, Diana Abbott, Maria L Amaya, Jonathan Gutman, Andrew Kent, Christine M. McMahon, Marc Schwartz, Clayton Smith, Jessica Dell-Martin, Connor Sohalski, Alexandra Ellis, Mary Haag, Jeffrey Schowinsky, Zenggang Pan, Sweta B Patel, Monica Ransom, Austin E Gillen, Eric M. Pietras, Craig T Jordan
Journal: Blood
Blood (2024) 144 (Supplement 1): 1828.
https://doi.org/10.1182/blood-2024-199336
Published: 2024
Journal Articles

Comparison of Myeloablative Conditioning with a Total Body Irradiation-Based Regimen Versus a Chemotherapy-Based Regimen in Adult Patients Undergoing Umbilical Cord Blood Stem Cell Transplant for Ph-Negative Acute Lymphoblastic Leukemia

Jason S. Gilbert, Andrew Kent, Jonathan Gutman, Maria L Amaya, Christine M. McMahon, Daniel A Pollyea, Marc Schwartz
Journal: Blood
Blood (2024) 144 (Supplement 1): 7280.
https://doi.org/10.1182/blood-2024-200993
Published: 2024
Journal Articles

Efficacy and Molecular Predictors of Response and Survival for Venetoclax/Azacitidine Therapy in Relapsed or Refractory Acute Myeloid Leukemia

Jason S. Gilbert, Megan Connor, Grace Bosma, Christine M. McMahon, Maria L Amaya, Jonathan Gutman, Marc Schwartz, Andrew Kent, Diana Abbott, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 4266.
https://doi.org/10.1182/blood-2024-199862
Published: 2024
Journal Articles

Results from a Clinical Study of the All-Oral Regimen of CC-486 (Oral Azacitidine) and Venetoclax for Newly Diagnosed and Relapsed and Refractory Acute Myeloid Leukemia

Maria L Amaya, Christine M. McMahon, Marc Schwartz, Jonathan Gutman, Andrew Kent, Diana Abbott, Connor Sohalski, Jessica Dell-Martin, Ayele Belachew, Brett M Stevens, Craig T Jordan, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 4259.
https://doi.org/10.1182/blood-2024-202839
Published: 2024
Journal Articles

Venetoclax Plus Azacitidine for Newly Diagnosed Younger Acute Myeloid Leukemia Patients Independent of Fitness for Intensive Chemotherapy

Justin M. Watts, Connor Sohalski, Alessia Zoso, Jessica Dell-Martin, Ayele Belachew, Diana Abbott, Maria L Amaya, Andrew Kent, Christine M. McMahon, Marc Schwartz, Mikkael A. Sekeres, Clayton Smith, Sangeetha Venugopal, Craig T Jordan, Mary Berg, Mary Haag, Nicholas Willard, Dara Aisner, Jeffrey Schowinsky, Zenggang Pan, Jingjing Zhang, Jonathan Gutman, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 969.
https://doi.org/10.1182/blood-2024-199267
Published: 2024
Journal Articles

Access to Novel Therapies Impacts Overall Survival (OS) in Low Socioeconomic (SES) Acute Myeloid Leukemia (AML) Patients (Pts)

Cassandra Duarte, Diana Abbott, Christine M. McMahon, Andrew Kent, Marc Schwartz, Jonathan Gutman, Daniel A Pollyea, Maria L Amaya
Journal: Blood
Blood (2024) 144 (Supplement 1): 3803.
https://doi.org/10.1182/blood-2024-201061
Published: 2024
Journal Articles

Outcomes of Haplo-Cord and Dual-Cord Transplants: A Single-Center Retrospective Analysis

Michael K Jones, Andrew Kent, Kellen Gil, Enkhtsetseg Purev, Bradley M. Haverkos, Marc Schwartz, Christine M. McMahon, Maria L Amaya, Grace N Bosma, Rachel Rabinovitch, Daniel A. Pollyea, Jonathan A Gutman
Journal: Blood
Blood (2023) 142 (Supplement 1): 7084.
https://doi.org/10.1182/blood-2023-190558
Published: 2023
Journal Articles

Higher-Dose Venetoclax with Measurable Residual Disease-Guided Azacitidine Discontinuation in Newly Diagnosed Patients with Acute Myeloid Leukemia: Phase 2 Hiddav Study

Jonathan A. Gutman, Amanda C. Winters, Andrew Kent, Maria L. Amaya, Christine M. McMahon, Clayton Smith, Craig T Jordan, Brett M. Stevens, Mohammad Minhajuddin, Shanshan Pei, Jeffrey Schowinsky, Jennifer Tobin, Kelly O'Brien, Angela Falco, Elizabeth Taylor, Constance Brecl, Phuong Ho, Connor Sohalski, Jessica Dell-Martin, Olivia Ondracek, Diana Abbott, Daniel A. Pollyea
Journal: Blood
Blood (2022) 140 (Supplement 1): 3275–3276.
https://doi.org/10.1182/blood-2022-157802
Published: 2022
Journal Articles

Non-Relapse Mortality in TP53 -Mutated MDS/AML - a Multi-Center Collaborative Study

Michael T. Byrne, Tony J Kurian, Dilan A Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C. Logan, Catherine J. Lee, Muhammad Husnain, Benjamin M Manning, Nicholas P. Tschernia, Ajoy L. Dias, Daniel Margalski, Benjamin Goldenson, Nathalie Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka M. Sengsayadeth, Aaron M Goodman, Dianna S. Howard, William A. Wood, Saar Gill, Antonio M. Jimenez, Jonathan A. Gutman, Lohith Gowda, Leland Metheny, III, Bhavana Bhatnagar, Betty K. Hamilton, Asmita Mishra, Michael R. Savona
Journal: Blood
Blood (2021) 138 (Supplement 1): 2922.
https://doi.org/10.1182/blood-2021-154151
Published: 2021
Journal Articles

Venetoclax Is Safe and Tolerable As Post-Transplant Maintenance Therapy for AML Patients at High Risk for Relapse

Andrew Kent, MD PhD, Daniel A. Pollyea, Amanda Winters, MDPhD, Craig T. Jordan, PhD, Clayton Smith, MD, Jonathan A. Gutman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-138832
Published: 2020
Journal Articles

A Phase 2 Study of Glasdegib for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with High Risk of Post-Allogeneic Stem Cell Transplantation Relapse

Andrew Kent, MD PhD, Sumithira Vasu, MDMBBS, Derek Schatz, Natalie Monson, Steven Devine, MD, Clayton Smith, MD, Jonathan A Gutman, MD, Daniel A Pollyea, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1311.
https://doi.org/10.1182/blood-2019-127418
Published: 2019